Literature DB >> 4627581

Reversal by a specific peptide (diacetyl-alpha gamma-L-diaminobutyryl-D-alanyl-D-alanine) of vancomycin inhibition in intact bacteria and cell-free preparations.

M Nieto, H R Perkins, P E Reynolds.   

Abstract

Vancomycin inhibited the growth of Bacillus megaterium, Staphylococcus aureus and Micrococcus lysodeikticus, and in cell-free preparations from B. megaterium it inhibited the formation of mucopeptide and enhanced the accumulation of the lipid intermediate in the biosynthetic pathway. All these inhibitory processes were reversed by the presence of a synthetic peptide analogous to un-cross-linked mucopeptide side chains, namely diacetyl-l-diaminobutyryl-d-alanyl-d-alanine. A considerable amount of vancomycin was found in recovering cells, whether recovery was caused by peptide or took place naturally because a low initial concentration of antibiotic was used. In cell-free preparations pretreated with vancomycin, continued inhibition of mucopeptide synthesis depended on the presence of cell-wall material. This inhibition was also reversible by added peptide.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4627581      PMCID: PMC1178359          DOI: 10.1042/bj1260139

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Vancomycin adsorption to Bacillus subtilis cell walls.

Authors:  G K Best; N N Durham
Journal:  Arch Biochem Biophys       Date:  1965-09       Impact factor: 4.013

2.  Structure of a lipid intermediate in cell wall peptidoglycan synthesis: a derivative of a C55 isoprenoid alcohol.

Authors:  Y Higashi; J L Strominger; C C Sweeley
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

3.  Biosythesis of the peptidoglycan of bacterial cell walls. II. Phospholipid carriers in the reaction sequence.

Authors:  J S Anderson; M Matsuhashi; M A Haskin; J L Strominger
Journal:  J Biol Chem       Date:  1967-07-10       Impact factor: 5.157

4.  On the initial stage in peptidoglycan synthesis. Phospho-N-acetylmuramyl-pentapeptide translocase (uridine monophosphate).

Authors:  W G Struve; R K Sinha; F C Neuhaus
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

5.  Compounds formed between nucleotides related to the biosynthesis of bacterial cell wall and vancomycin.

Authors:  A N Chatterjee; H R Perkins
Journal:  Biochem Biophys Res Commun       Date:  1966-08-12       Impact factor: 3.575

6.  Iodinated vancomycin and mucopeptide biosynthesis by cell-free preparations from Micrococcus lysodeikticus.

Authors:  C Bordet; H R Perkins
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

7.  Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

Authors:  H R Perkins
Journal:  Biochem J       Date:  1969-01       Impact factor: 3.857

8.  Relative affinity of vancomycin and ristocetin for cell walls and uridine diphosphate-N-acetylmuramyl pentapeptide.

Authors:  G K Best; M K Grastie; R D McConnell
Journal:  J Bacteriol       Date:  1970-05       Impact factor: 3.490

9.  Reversal of the vancomycin inhibition of peptidoglycan synthesis by cell walls.

Authors:  R K Sinha; R C Neuhaus
Journal:  J Bacteriol       Date:  1968-08       Impact factor: 3.490

10.  The preparation of iodinated vancomycin and its distribution in bacteria treated with the antibiotic.

Authors:  H R Perkins; M Nieto
Journal:  Biochem J       Date:  1970-01       Impact factor: 3.857

View more
  12 in total

Review 1.  Resistance of enterococci to glycopeptides.

Authors:  P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

2.  Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus.

Authors:  Deborah L Higgins; Ray Chang; Dmitri V Debabov; Joey Leung; Terry Wu; Kevin M Krause; Erik Sandvik; Jeffrey M Hubbard; Koné Kaniga; Donald E Schmidt; Qiufeng Gao; Robert T Cass; Dane E Karr; Bret M Benton; Patrick P Humphrey
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.

Authors:  S al-Obeid; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

4.  Characterization of a stable L-form of Bacillus subtilis 168.

Authors:  R W Gilpin; F E Young; A N Chatterjee
Journal:  J Bacteriol       Date:  1973-01       Impact factor: 3.490

5.  Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic.

Authors:  N E Allen; J N Hobbs; T I Nicas
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 6.  Structure, biochemistry and mechanism of action of glycopeptide antibiotics.

Authors:  P E Reynolds
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-11       Impact factor: 3.267

7.  Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.

Authors:  N E Allen; D L LeTourneau; J N Hobbs
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

8.  The synthesis of peptidoglycan in an autolysin-deficient mutant of Bacillus licheniformis N.C.T.C. 6346 and the effect of beta-lactam antibiotics, bacitracin and vancomycin.

Authors:  J B Ward
Journal:  Biochem J       Date:  1974-07       Impact factor: 3.857

9.  Inhibition of peptidoglycan synthesis by the antibiotic diumycin A.

Authors:  E J Lugtenberg; J A Hellings; G J van de Berg
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

10.  Vancomycin resistance in Enterococcus gallinarum.

Authors:  S Vincent; P Minkler; B Bincziewski; L Etter; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.